Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jodie Pope Morrison Insider Profile
4 Followers
Jodie Pope Morrison, President & CEO, Director at Novus Therapeutics, holds 58.62K shares in Akebia Therapeutics (Ticker: AKBA), holds 0.00 shares in Keryx Biopharma (Ticker: KERX), holds 57.57K shares in Novus Therapeutics (Ticker: NVUS).
Jodie Pope Morrison Novus Therapeutics (NVUS)President & CEO, Director
Novus Therapeutics (NVUS)
President & CEO, Director
Ranked #71,128 out of 78,624 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-71.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jodie Pope Morrison holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jodie Pope Morrison
Jodie Pope Morrison's Trading History
Novus Therapeutics
Jan 08, 2016
President & CEO, Director
Informative Buy
32.45K
$1.46M
Keryx Biopharma
Dec 13, 2018
―
Uninformative Sell
―
$0.00
Aileron Therapeutics
―
Director
―
―
Akebia Therapeutics
Jun 10, 2019
Director
Uninformative Buy
―
$198.72K
List of latest transactions for each holding click on a transaction to see Jodie Pope Morrison's performance on stock
You May Also Like
Jodie Pope Morrison insider profile FAQ
What is the percentage of profitable transactions made by Jodie Pope Morrison?
The percentage of profitable transactions made by Jodie Pope Morrison is 0%.
What is the average return per transaction made by Jodie Pope Morrison?
The average return per transaction made by Jodie Pope Morrison is -71.80%.
What stocks does Jodie Pope Morrison hold?
Jodie Pope Morrison holds: NVUS, KERX, ALRN, AKBA stocks.
What was Jodie Pope Morrison’s latest transaction?
Jodie Pope Morrison latest transaction was an Uninformative Buy of ―.
What was Jodie Pope Morrison's most profitable transaction?
Jodie Pope Morrison’s most profitable transaction was an Informative Buy of NVUS stock on July 24, 2015. The return on the trade was -61.20%.
What is Jodie Pope Morrison's role in Novus Therapeutics?
Jodie Pope Morrison's role in Novus Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.